Gül Ayanoğlu Dülger
Marmara University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gül Ayanoğlu Dülger.
Journal of Pineal Research | 2003
Goksel Sener; Ahmet Ozer Sehirli; Kübra Paskaloglu; Gül Ayanoğlu Dülger; Inci Alican
Abstract: Reactive oxygen metabolites play important roles in ischemia/reperfusion (I/R) injury in several systems. The aim of this study was to investigate the role of melatonin against I/R injury of the rat urinary bladder. The abdominal aorta was clamped to induce ischemia for 30 min, then the animals were subjected to 60 min of reperfusion. Melatonin (10 mg/kg, i.p.) or the vehicle (control 1% alcohol i.p.) was administered before I/R. After decapitation, the bladder was removed and the tissue was either used for functional studies or stored for measurement of products of lipid peroxidation (LP), glutathione (GSH) levels and myeloperoxidase activity (MPO). Bladder strips were suspended in oxygenated Tyrodes buffer at 37°C and isometric contractions to carbachol (CCh; 10−8–10−4 m) were recorded.
Pharmacy Practice (internet) | 2012
Hale Z. Toklu; Gül Ayanoğlu Dülger; Seyhan Hıdıroğlu; Ahmet Akici; Aslıhan Yetim; H. Mustafa Gannemoğlu; Haşim Güneş
The use of generic drugs has increased significantly in recent years. Since generic drugs are available at a lower cost, they provide an opportunity for savings in drug expenditure. Thus, use of generic drugs is encouraged especially in developing countries. There are only a few studies concerning the perceptions and attitudes of the healthcare providers and patients towards generic drug use. Methods The present study was conducted by a face to face questionnaire in the Kadikoy district of Istanbul in April 2010. From randomly chosen respondents, 68 pharmacists, 56 prescribers and 101 patients consented to participate in the study. Results Thirty one and 32 % of the pharmacists and prescribers, respectively, expressed that they believed that the generics did not differ from the original drugs, whereas only 24% of the patients believed so. Forty percent of the pharmacists and 82% of the prescribers told that they were unsure about the bioequivalence of the generics. Ten percent of the patients claimed that they immediately accept generic substitution by the pharmacist, while 26% accepted it if it was substituted by the prescriber. Cost was the most important factor taken into consideration about generic substitution (92% for prescribers; 83% for patients and 82% for pharmacists). Conclusions Our findings demonstrated that healthcare providers as well as the drug consumers have insufficient knowledge about generic drugs. Therefore, they should be better educated with respect to generic substitution.
Burns | 2007
Göksel Şener; A. Özer Şehirli; Nursal Gedik; Gül Ayanoğlu Dülger
Marmara Pharmaceutical Journal | 2012
Hale Z. Toklu; Rümeysa Demirdamar; Bulent Gumusel; Ersin Yaris; Gül Ayanoğlu Dülger
Marmara Pharmaceutical Journal | 2012
Gül Ayanoğlu Dülger
Turkish Journal of Family Practice | 2010
Ahmet Akici; Gül Ayanoğlu Dülger; Hale Z. Toklu; Meral Keyer Uysal
Archive | 2009
F. İlkay Alp; Gül Ayanoğlu Dülger; Bulent Gumusel; Özge Gündüz; Levent Kabasakal; Deniz Kaleli Durman; Pelin Kelicen; Zeliha Kerry; Mehmet Melli; Arzu Onay; Latif Özbay; Osman Özdemir; Gülnur Sevin; Asli Özer; Banu Cahide Tel; Hale Z. Toklu; Nilüfer N. Turan; M. Betül Yerer
Marmara Pharmaceutical Journal | 2011
Hale Z. Toklu; Gül Ayanoğlu Dülger
Archive | 2007
Soner Saniolu; Onur Sokullu; Levent Kabasakal; Yavuz Enc; Ali Tabakan; Gül Ayanoğlu Dülger; Fuat Bilgen
Gastroenterology | 2003
Goksel Sener; Figen Onuk Goren; Gül Ayanoğlu Dülger